1Cohen AF, Van Bronswijk H. New medications :bevacizumab[ J ]. Ned Tijdschr Geneeskd,2006,150 (40) :2194-2195.
2Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age2related macular degeneration [ J ]. Ophthalmic Surg Lasers I mag, 2005,36(3) :331-335.
3Byeon SH, Kwon YA, Oh HS, et al. Short2term result of intravitreal bevacizumab for macular edema with retinal vein obstruction and diabetic macula edema[ J]. J Ocul Pharmacol Ther,2007,23 (4) :387-394.
5Hosseini H, Khalili MR. Therapeutic potential of be vacizumab ( Avastin) in herpetic stromal keratitis (HSK) [ J]. Med Hypotheses, 2007, 69 (3) :568-570.
6Manzano RP, Peyman GA, Khan P, et al. Inhibition of experimental corneal neovascula2risati on by bevacizumab ( Avastin ) [ J ] . Br J Ophthamol,2007, 91 (6) :804-807.
7Destafeno JJ, Kim T. Topical bevacizumab therapy for corneal neovas-cularizati on[J]. Arch Ophthalmol,2007,125 (6) : 834- 836.
8Rosenfeld PJ, Schwartz SD, Blumenkranz MS, et al. Maximum tolerated dose of a humanized antivascular endothelial growth fact or antibody fragment for treating neovascular age2related macular degeneration[ J ]. Ophthalmology,2005,112 (6) : 1048- 1053.
9La Cour M. IntravitrealVEGF-inhibitors is Avastin ageneric substitute for Lucentis [J] . Acta Ophthalmol Scand,2007, 85 (1) : 224.
10Shukla D, Namperumalsamy P, Goldbaum M, et al. Pegaptanib so-dim for ocular vascular disease [ J ]. Indian Ophthalmol, 2007,55 ( 6 ) :427- 430.
8Klein R, Klein BE, Moss SE. Visual impairment in diabetes[J]. Ophthalmology, 1984,91 : 1 - 9
9Early Treatment Diabetic Retinopathy Study Research Group. Early treatment diabetic retinopathy study report number 1. Photocoagulation for diabetic macular edema [ J ]. Arch Ophthalmol, 1985, 103 ( 12 ) : 1796 - 1806
10Gilliies MC, Kuzniarz M, Craig J, et al. lntravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract[ J ]. Ophthahnology ,2005,112:139 - 143
10Sutherland BA, Rahman RMA, Clarkson AN, et al. Cerebral heine ox- ygenase land 2 spatial distribution is modulated following injury from hypoxia-ischemia and middle cerebral artery occlusion in rats [ J ]. Neurosci Res ,2009,65:326-334.
